Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 6535-6538, July 15, 2007. doi: 10.1158/0008-5472.CAN-07-1271
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, M. M.
Right arrow Articles by Abate-Shen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, M. M.
Right arrow Articles by Abate-Shen, C.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Invasion and Metastasis

Reviews

Pten Inactivation and the Emergence of Androgen-Independent Prostate Cancer

Michael M. Shen1 and Cory Abate-Shen2

Center for Advanced Biotechnology and Medicine and Departments of 1 Pediatrics and 2 Medicine, The Cancer Institute of New Jersey, University of Medicine and Dentistry, New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey

Requests for reprints: Michael M. Shen, CABM, 679 Hoes Lane, Piscataway, NJ 08854. Phone: 732-235-5645; Fax: 732-235-5373; E-mail: mshen{at}cabm.rutgers.edu and Cory Abate-Shen, CABM, 679 Hoes Lane, Piscataway, NJ 08854. Phone: 732-235-5161; Fax: 732-235-5789; E-mail: abate{at}cabm.rutgers.edu.

Hormone refractory disease represents a late-stage and generally lethal event in prostate tumorigenesis. Analyses of mouse models have recently shown that the onset of hormone independence can be uncoupled from disease progression and is associated with activation of the phosphoinositide-3 kinase/Akt as well as Erk mitogen-activated protein kinase signaling pathways in the prostate epithelium, which act in part to counterbalance the inhibitory effects of androgen receptor signaling in the prostate stroma. These observations have potential implications for the treatment of patients with hormone refractory cancer and highlight the role of epithelial-stromal interactions for androgen independence. [Cancer Res 2007;67(14):6535–8]




This article has been cited by other articles:


Home page
Cancer Res.Home page
X. Ouyang, W. J. Jessen, H. Al-Ahmadie, A. M. Serio, Y. Lin, W.-J. Shih, V. E. Reuter, P. T. Scardino, M. M. Shen, B. J. Aronow, et al.
Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer
Cancer Res., April 1, 2008; 68(7): 2132 - 2144.
[Abstract] [Full Text] [PDF]


Home page
CRO ContentHome page
G. C. Prendergast
Recent Movement to Exploit Key Signaling Molecules and Cancer Vaccines
Cancer Reviews Online Content, August 1, 2007; 2007(5): 9 - 9.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.